Immuneering (IMRX) Depreciation and Depletion (2020 - 2024)
Immuneering's (IMRX) quarterly Depreciation and Depletion came in at $86116.0 in Q4 2024, down 4.05% year-on-year from $89754.0 in Q1 2024, and down 3.18% quarter-over-quarter from $88949.0 in Q3 2024.
Immuneering (IMRX) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Immuneering's Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $86116.0 for Q4 2024.
- On a quarterly basis, Depreciation and Depletion fell 4.05% year-over-year to $86116.0 in Q4 2024; TTM through Dec 2024 was $355807.0, a 10.22% increase from a year earlier, with the FY2024 full-year figure at $355807.0, up 10.22% from the prior year.
- Depreciation and Depletion slipped to $86116.0 in Q4 2024 per IMRX's latest filing, from $88949.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $90533.0 in Q2 2024 and bottomed at $5656.0 in Q3 2020.
- The 5-year median for Depreciation and Depletion is $68075.0 (2022), against an average of $52121.7.
- Across the five-year window, Depreciation and Depletion jumped 468.33% in 2022 and declined 4.05% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $7449.0 in 2020, then jumped by 98.89% to $14815.0 in 2021, then soared by 418.81% to $76862.0 in 2022, then climbed by 16.77% to $89754.0 in 2023, then decreased by 4.05% to $86116.0 in 2024.
- Per Business Quant, the three latest IMRX Depreciation and Depletion figures stand at $86116.0 (Q4 2024), $88949.0 (Q3 2024), and $90533.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Immuneering | 283.85 Mn | 283.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 86,116.00 |
| Dec 31, 2024 | 86,116.00 |
| Sep 30, 2024 | 88,949.00 |
| Sep 30, 2024 | 88,949.00 |
| Jun 30, 2024 | 90,533.00 |
| Jun 30, 2024 | 90,533.00 |
| Mar 31, 2024 | 90,209.00 |
| Mar 31, 2024 | 90,209.00 |
| Dec 31, 2023 | 89,754.00 |
| Dec 31, 2023 | 89,754.00 |
| Sep 30, 2023 | 78,294.00 |
| Sep 30, 2023 | 78,294.00 |
| Jun 30, 2023 | 78,241.00 |
| Jun 30, 2023 | 78,241.00 |
| Mar 31, 2023 | 76,527.00 |
| Mar 31, 2023 | 76,527.00 |
| Dec 31, 2022 | 76,862.00 |
| Dec 31, 2022 | 76,862.00 |
| Sep 30, 2022 | 68,075.00 |
| Sep 30, 2022 | 68,075.00 |